Decreased expression of tumor necrosis factor-α in failing human myocardium after mechanical circulatory support: A potential mechanism for cardiac recovery

Circulation

Volumn 100, Issue 11, 1999, Pages 1189-1193

  Torre Amione, Guillermo ^a,c   Stetson, Sonny J ^a   Youker, Keith A ^a   Durand, Jean Bernard ^a   Radovancevic, Branislav ^b   Delgado, Reynolds M ^b   Frazier, O H ^b   Entman, Mark L ^a   Noon, George P ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b TEXAS HEART INSTITUTE   (United States)

^c NONE   (United States)

Author keywords

Heart assist device; Heart failure; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ASSISTED CIRCULATION; CYTOKINE PRODUCTION; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE OVERLOAD; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033554456     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.11.1189     Document Type: Article

References (21)

1. Braunwald E. ACE inhibitors: a cornerstone of the treatment of heart failure. N Engl J Med. 1991;325:351-353.
2. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.
3. Muller J, Wallulkat G, Weng YG, Dandel M, Spiegelsberger S, Semrau S, Brandes KV, Loebe M, Meyer R, Hetzer R. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997;96:542-549.
4. Levin ROM, Catanese K, Rose EA, Burkhoff D. Transient normalization of systolic and diastolic function after LVAD support in a patient with dilated cardiomyopathy. J Heart Lung Transplant. 1996;15:840-842.
5. Frazier OH, Benedict C, Radovancevic B, Bick RJ, Capek P, Springer WE, Macris MP, Delgado R, Buja LM. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Sure 1996;62: 675-681.
6. Delgado RM, Radovancevic B, Massin EK, Frazier OH, Benedict C. Neurohormonal changes following implantation of the left ventricular assist device and implications for its weanability ASAIO 1998;444: 299-330.
7. McCarthy PM, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg. 1995;59:609-613.
8. Zafeiridis A, Jeevanandam V, Houser SR, Margulies KB. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 1998;98:656-662.
9. Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 1994;105: 897-904.
10. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol. 1996;5:1291-1296.
11. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med. 1990;223:236-241.
12. Kubota T, McTiernan CF, Frye CS, Slawson SE, Koretsky AP, Demetris AJ, Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-alpha. Circ Res. 1997;81:627-635.
13. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, Giroir B. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation. 1998;97: 1375-1381.
14. Kapadia S, Oral H, Lee J, Taffet G, Mann DL. Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circ Res. 1997;81:187-195.
15. Torre-Amione G, Kapadia S, Lee J, Durand J-B, Bies RD, Young JB, Mann DL. Tumor necrosis factor-a and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
16. Matsuo T, Mori H, Nishimura Y, Maeda T, Nakagawa J-I, Obashi A. Quantification of immunohistochemistry using an image analyser: correlation with hormone concentrations in pituitary adenomas. Histochem J. 1995;27:989-996.
17. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy Circulation. 1995;92:778-784.
18. Sadoshima J, Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 1993;12:1681-1692.
19. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc Res. 1995;31:625-632.
20. Bozkurt B, Kribbs S, Clubb M Jr, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale F, Mann DL. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation. 1998;97:1382-1391.
21. Deswal A, Bozkurt B, Seta Y, Parilti-Elswirtti S, Hayes FA, Blosch C, Mann DL. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, Etanercept) in patients with advanced heart failure. Circulation. 1999;99:3224-3226.